HeartSciences
$2.36
29
-$0.15-6.13% Wednesday 20:00
Statistics
Day High
2.6
Day Low
2.28
52W High
6.47
52W Low
2.01
Volume
9,880
Avg. Volume
21,024
Mkt Cap
7.5M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16MarExpected
Expected EPS
-1.12
Actual EPS
-0.63
Financials
-219,125%Profit Margin
Unprofitable8,000Revenue
-17.53MNet Income
Analyst Ratings
$8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow HSCS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Medtronic
MDT
Mkt Cap116.33B
Boston Scientific
BSX
Mkt Cap149.24B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
GE Aerospace
GE
Mkt Cap325.88B
Siemens
SIEGY
Mkt Cap224.45B
Hologic
HOLX
Mkt Cap16.45B
Baxter International
BAX
Mkt Cap9.49B
Becton Dickinson
BDX
Mkt Cap51.22B
About
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Show more...
CEO
Mr. Andrew Simpson
Employees
15
Country
US
ISIN
US42254E3027
Listings
0 Comments
Share your thoughts
FAQ
What is HeartSciences stock price today?▼
The current price of HSCS is $2.36 USD — it has decreased by -6.13% in the past 24 hours. Watch HeartSciences stock price performance more closely on the chart.
What is HeartSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HeartSciences stocks are traded under the ticker HSCS.
Is HeartSciences stock price growing?▼
HSCS stock has risen by +2.16% compared to the previous week, the month change is a -11.28% fall, over the last year HeartSciences has showed a -15.71% decrease.
What is HeartSciences market cap?▼
Today HeartSciences has the market capitalization of 7.5M
When is the next HeartSciences earnings date?▼
HeartSciences is going to release the next earnings report on July 22, 2026.
What were HeartSciences earnings last quarter?▼
HSCS earnings for the last quarter are -0.63 USD per share, whereas the estimation was -1.12 USD resulting in a +43.75% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HeartSciences revenue for the last year?▼
HeartSciences revenue for the last year amounts to 8,000 USD.
What is HeartSciences net income for the last year?▼
HSCS net income for the last year is -17.53M USD.
How many employees does HeartSciences have?▼
As of April 02, 2026, the company has 15 employees.
In which sector is HeartSciences located?▼
HeartSciences operates in the Health Care sector.
When did HeartSciences complete a stock split?▼
The last stock split for HeartSciences was on May 17, 2024 with a ratio of 1:100.
Where is HeartSciences headquartered?▼
HeartSciences is headquartered in Southlake, US.